Corticotropin-releasing factor 2 receptor localization in skeletal muscle

Journal of Histochemistry and Cytochemistry

Volumn 52, Issue 7, 2004, Pages 967-977

  Samuelsson, Steven ^a,c   Lange, Jana S ^a   Hinkle, Richard T ^a   Tarnopolsky, Mark ^b   Isfort, Robert J ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c Eyetech Pharmaceuticals Inc   (United States)

Author keywords

Corticotropin releasing factor; Neural tissues; Receptor; Skeletal muscle

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; MALE; MECHANORECEPTOR; MUSCLE SPINDLE; NERVE FIBER; NERVOUS TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SKELETAL MUSCLE; TENDON RECEPTOR;

ANIMALS; BLOOD VESSELS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NERVE TISSUE; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SPECIES SPECIFICITY;

ANIMALIA; RODENTIA;

EID: 3042737570     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.4A6279.2004     Document Type: Article

References (48)

1. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, et al. (2000) Mice deficient for corticotropin-releasing hormone receptor 2 display anxiety-like behavior and are hypersensitive to stress. Nature Genetics 24:410-414
2. Bale TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL, Vale WW, et al. (2002) Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci USA 99:7734-7739
3. Blumer R, Wasicky R, Hotzenecker W, Lukas JR (2001) Presence and structure of innervated myotendinous cylinders in rabbit extraocular muscle. Exp Eye Res 73:787-796
4. Bray JJ, Harris AJ (1975) Dissociation between nerve-muscle transmission and nerve trophic effects on rat diaphragm using type D botulinum toxin. J Physiol 253:53-77
5. Carlsson L, Li Z, Paulin D, Thornell LE (1999) Nestin is expressed during development and in myotendinous and neuromuscular junctions in wild type and desmin knockout mice. Exp Cell Res 251:213-223
6. Chalmers DT, Lovenberg TW, Gridoriadis DE, Behan DP, De Souza EB (1996) Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol Sci 17:166-172.
7. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, et al. (2000) Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor 2. Nature Genet 24:403-409
8. Dautzenberg FM, Hauger RL (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23:71-77
9. Davis HL (1983) Trophic action of nerve extract on denervated skeletal muscle in vivo: dose dependency, species specificity, and timing of treatment. Exp Neurol 80:383-394
10. De Souza EB (1995) Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20:789-819
11. Dieterich KD, Lehnert H, De Souza EB (1997) Corticotropin-releasing factor receptors: an overview. Exp Clin Endocrinol Diabetes 10:65-82
12. Fernandez HL, Ross GS, Nadelhaft I (1999) Neurogenic calcitonin gene-related peptide: a neurotrophic factor in the maintenance of acetylcholinesterase molecular forms in adult skeletal muscle. Brain Res 844:83-97
13. Fleisher-Berkovich S, Danon A (1995) Effect of corticotropin-releasing factor on prostaglandin synthesis in endothelial cells and fibroblasts. Endocrinology 136:4068-4072
14. Garzon J, Hollt V, Schulz R, Herz A (1985) Excitatory neuropeptides activate opioid mechanisms in the guinea pig ileum. Neuropeptides 5:583-586
15. Grill HJ, Markison S, Ginsberg A, Kaplan JM (2000) Long-term effects on feeding and body weight after stimulation of fore-brain or hindbrain CRH receptors with urocortin. Brain Res 867:19-28
16. Heldwein KA, Duncan JE, Stenzel P, Rittenberg MB, Stenzel-Poore MP (1997) Endotoxin regulates corticotropin-releasing hormone receptor 2 in heart and skeletal muscle. Mol Cell Endocrinol 131:167-172
17. Helgren ME, Squinto SP, Davis HL, Parry DJ, Boulton TG, Heck CS, Zhu Y, et al. (1994) Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell 76:493-504
18. Heymann-Monnikes I, Tache Y, Trauner M, Weiner H, Garrick T (1991) CRF microinjected into the dorsal vagal complex inhibits TRH analog- and kainic acid-stimulated gastric contractility in rats. Brain Res 554:139-144
19. Hinkle RT, Donnelly E, Cody DB, Samuelsson S, Lange JS, Bauer MB, Tarnopolsky M, et al. (2003) Activation of the CRF2 receptor modulates skeletal muscle mass under physiological and pathological conditions. Am J Physiol 285:E889-898
20. Hsu SY, Hsueh AJ (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nature Med 7:605-611
21. Hunt CC (1990) The mammalian muscle spindle: peripheral mechanisms. Physiol Rev 70:643
22. Kawabuchi M, Zhou CJ, Wang S, Nakamura K, Liu WT, Hirata K (2001) The spatiotemporal relationship among Schwann cells, axons and postsynaptic acetylcholine receptor regions during muscle reinnervation in aged rats. Anat Rec 264:183-202
23. Kihara N, Fujimura M, Yamamoto I, Itoh E, Inui A, Fujimiya M (2001) Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats. Am J Physiol 280:G406-419
24. Kishimoto T, Pearse RN, Lin CR, Rosenfeld MG (1995) A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92:1108-1112
25. Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F, Hermanson O, et al. (2000) Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nature Genet 24:415-419
26. Krikler DM, Rode J, Davies MJ, Woolf N, Moss E (1992) Atrial myxoma: a tumour in search of its origins. Br Heart J 67:89-91
27. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, et al. (2001) Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570-7575
28. Lovenberg TW, Chalmers DT, Liu C, De Souza EB (1995) CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136:4139-4142
29. Markelonis GJ, Kemerer VF, Oh TH (1980) Sciatin: purification and characterization of a myotrophic protein from chicken sciatic nerves. J Biol Chem 255:8967-8970
30. Marques MJ, Neto HS (1997) Ciliary neurotrophic factor stimulates in vivo myotube formation in mice. Neurosci Lett 234:43-46
31. Martinez V, Wang L, Rivier JE, Vale W, Tache Y (2002) Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 301:611-617
32. McAlexander MA, Undem BJ (1997) Enhancement of tachykinin-induced contractions of guinea pig isolated bronchus by corticotropin-releasing factor. Neuropeptides 31:293-299
33. McCarthy JR, Heinrichs SC, Grigoriadis DE (1999) Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Curr Pharmacol Des 5:289-315
34. Mense S, Meyer H (1985) Different types of slowly conducting afferent units in the cat skeletal muscle and tendon. J Physiology 363:403-417
35. Miampamba M, Maillot C, Million M, Tache Y (2002) Peripheral CRF activates myenteric neurons in the proximal colon through CRF(1) receptor in conscious rats. Am J Physiol 282:G857-865
36. Nahirney PC, Ovalle WK (1993) Distribution of dystrophin and neurofilament protein in muscle spindles of normal and Mdx dystrophic mice: an immunocytochemical study. Anat Rec 235:501-510
37. Nora EH, Munzenmaier DH, Hansen-Smith FM, Lombard JH, Greene AS (1998) Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle. Am J Physiol 275: H1395-1403
38. Radulovic J, Ruhmann A, Liepold T, Spiess J (1999) Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential role of CRF receptors 1 and 2. J Neurosci 19:5016-5025
39. Ralphs JR, Benjamin M, Thornett A (1991) Cell and matrix biology of the suprapatella in the rat: a structural and immunocytochemical study of fibrocartilage in a tendon subject to compression. Anat Rec 231:167-177
40. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, et al. (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843-2848
41. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, et al. (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093-1102
42. Stacey MJ (1969) Free nerve endings in skeletal muscle of the cat. J Anat 105:231-254
43. Swett JE, Schoultz TW (1975) Mechanical transduction in the Golgi tendon organ. A hypothesis. Arch Ital Biol 113:374-382
44. Tamaoki J, Sakai N, Kobayashi K, Kanemura T, Shibasaki T, Takizawa T (1998) Corticotropin-releasing factor potentiates the contractile response of rabbit airway smooth muscle to electrical field stimulation but not to acetylcholine. Am Rev Respir Dis 140:1331-1335
45. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, et al. (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genet 19:162-16
46. Vaittinen S, Lukka R, Sahlgren C, Rantanen J, Hurme T, Lendahl U, Eriksson JE, et al. (1999) Specific and innervation-regulated expression of the intermediate filament protein nestin at neuromuscular and myotendinous junctions in skeletal muscle. Am J Pathol 154:591-600
47. Wang L, Martinez V, Vale W, Tache Y (2000) Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats. Brain Res 855:47-57
48. Yarnitzky T, Min L, Volk T (1997) The drosophila neuregalin homolog vein mediates inductive interactios between myotubes and their epidermal attachment cells. Genes Dev 11:2691-2700